Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00036582 · ClinicalTrials.gov registry record · Phase 3
Clozapine vs. Placebo in Treatment-Refractory Bipolar Disorder in Children and Adolescents
A Phase 3 study, sponsored by National Institute of Mental Health (NIMH).
- Completed
- Registry status
- Phase 3
- Development phase
- 116
- Enrollment target
NCT00036582: Completed Phase 3 study, sponsored by National Institute of Mental Health (NIMH).
NCT00036582 is a Phase 3 study that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 116 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00036582, a Phase 3 study, has completed, sponsored by National Institute of Mental Health (NIMH).
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 116 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the safety and effectiveness of clozapine in children and adolescents with treatment resistant bipolar disorder. This study will also explore how the brain functions in early-onset bipolar disorder.
Interventions
- DRUG Clozapine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2002-05 |
| Est. Completion | 2004-02 |
| Phase | Phase 3 |
What the finished NCT00036582 record still lists
NCT00036582 is an interventional study that assigns participants to a tested intervention. The registered 116 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 1 intervention - of which Clozapine is the first listed.
NCT00036582 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00036582 about?
NCT00036582 is a clinical study titled "Clozapine vs. Placebo in Treatment-Refractory Bipolar Disorder in Children and Adolescents". The purpose of this study is to determine the safety and effectiveness of clozapine in children and adolescents with treatment resistant bipolar disorder. This study will also explore how the brain functions in early-onset bipolar disorder.
What is the current status of trial NCT00036582?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 116 participants. The study started on 2002-05. Estimated completion is 2004-02.
What interventions are being tested in trial NCT00036582?
The interventions under investigation include: Clozapine (DRUG).
Who is sponsoring clinical trial NCT00036582?
This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00036582's enrollment target sits among peer trials
116 1643rd of 2000 higher than 357 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03014687 · 116 participants · Phase 4
Prophylactic Oral Antibiotics on Sinonasal Outcomes Following Endoscopic Transsphenoidal Surgery for Pituitary Lesions
- NCT03214562 · 116 participants · Phase 1
Venetoclax With Combination Chemotherapy in Treating Patients With Newly Diagnosed or Relapsed or Refractory Acute Myeloid Leukemia
- NCT03847467 · 116 participants · Phase 1
Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy
- NCT04222413 · 116 participants · Phase 1
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia